ClinicalTrials.gg
Drug

Pralatrexate clinical trials

Also written Folotyn and PDX.

studies test it
34
open now
3
in phase 3
3
first study started
1999

How each study uses pralatrexate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the pralatrexate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Sept 2009 · FOLOTYN · NDA 022468 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pralatrexate
27
Pralatrexate Injection
10
(RS)-10-propargyl-10-deazaaminopterin
8
10-propargyl-10-deazaaminopterin
4
Difolta
2

Brand

Folotyn
25

Development codes

PDX-010
1

Other names

PDX
14

Studies by the year they started

33 studies that test it; most in 2010 (8); 1 more planned to start later

Studies that test pralatrexate, by start year
YearStudies
19991
20021
20061
20072
20082
20091
20108
20112
20121
20133
20142
20152
20161
20181
20191
20222
20231
20261

Who runs them

Industry 19 · Other 15

Acrotech Biopharma Inc. (12) · Spectrum Pharmaceuticals, Inc (4) · City of Hope Medical Center (2) · University of Virginia (2) · University of Nebraska (2) · Memorial Sloan Kettering Cancer Center (2) · Mundipharma (China) Pharmaceutical Co. Ltd (1) · Massachusetts General Hospital (1)

Often tested with

Tested in the same studies.

Vitamin B 12 (3) · Folic Acid (3) · Cyclophosphamide (2) · Vincristine (2) · Prednisone (2) · Azacitidine (2) · Romidepsin (2) · Levoleucovorin (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Pralatrexate is the comparator. A study of two new drugs counts under both.

  • 1Soquelitinib · Corvus Pharmaceuticals, Inc. · next primary completion Nov 2027
Reaching primary completion within a year · 1

Studies that test pralatrexate.

Studies

Open first, then newest update. How each study uses pralatrexate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test pralatrexate →

Given beside what is tested · 1 — pralatrexate is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with pralatrexate

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call pralatrexate · ClinicalTrials.gg INT004294

  • UNII (FDA) A8Q8I19Q20PRALATREXATEConfirmed FDA, Wikidata
  • RxNorm 662019Confirmed FDA, Wikidata
  • Wikidata Q637059pralatrexateConfirmed FDA, Wikidata
  • NCI Thesaurus C2250PralatrexateOne source FDA
  • DrugBank DB06813One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.